Home/Filings/4/0000899243-18-020985
4//SEC Filing

Kelley Lynne E 4

Accession 0000899243-18-020985

CIK 0001372299other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:36 PM ET

Size

5.4 KB

Accession

0000899243-18-020985

Insider Transaction Report

Form 4
Period: 2018-07-31
Kelley Lynne E
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2018-07-31+200,000200,000 total
    Exercise: $2.21Exp: 2028-07-30Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]This option vests over four (4) years of service following August 6, 2018, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and the balance vesting in thirty-six (36) equal monthly installments thereafter.

Issuer

HISTOGENICS CORP

CIK 0001372299

Entity typeother

Related Parties

1
  • filerCIK 0001667584

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:36 PM ET
Size
5.4 KB